References
Baccarani M, Saglio G, Goldman J, et al. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 2006,108(6):1809–1820
Antarjian H, Sawyers C, Hochhaus A, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med, 2002,346(9):645–652
Gambacorti-Passerini C, Tornaghi L, Cavagnini F, et al. Gynaecomastia in men with chronic myeloid leukaemia after imatinib. Lancet, 2003,361(9373):1954–1956
Kim H, Chang HM, Ryu MH, et al. Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor. J Korean Med Sci, 2005,20(3):512–515
Cakan N, Kamat D. Gynecomastia: evaluation and treatment recommendations for primary care providers. Clin Pediatr (Phila), 2007,46(6):487–490
Eckman A, Dobs A. Drug-induced gynecomastia. Expert Opin Drug Saf, 2008,7(6):691–702
Bembo SA, Carlson HE. Gynecomastia: its features, and when and how to treat it. Cleve Clin J Med, 2004,71(6): 511–517
Asciani S, Mariani S, Arizzi M, et al. Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and -beta during human testicular development and disease. J Clin Endocrinol Metab, 2002, 87(5):2310–2319
Goldman RD. Drug-induced gynecomastia in children and adolescents. Can Fam Physician, 2010,56(4):344–345
Author information
Authors and Affiliations
Corresponding author
Additional information
Both authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhao, D., Wang, G., Li, C. et al. Bilateral masculine mastoplasia associated with imatinib mesylate: A case report and literature review. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 31, 145–146 (2011). https://doi.org/10.1007/s11596-011-0167-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-011-0167-z